(Q53365188)

English

Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party. (English)

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

1 reference

based on heuristic

inferred from title

16

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

author name string

I Kataoka

1

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

M Kami

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

S Takahashi

3

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

Y Kodera

4

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

S Miyawaki

5

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

N Hirabayashi

6

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

S Okamoto

7

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

N Matsumoto

8

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

Y Miyazaki

9

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

Y Morishita

10

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

O Asai

11

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

A Maruta

12

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

T Yoshida

13

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

M Imamura

14

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

N Hamajima

15

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

M Harada

17

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

S Mineishi

18

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

Japan Society for Hematopoietic Cell Transplantation Working Party

19

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

Bone Marrow Transplantation

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

34

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

8

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

711-719

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704659

0 references

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

21 January 2018

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

21 January 2018

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

21 January 2018

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

21 January 2018

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

21 January 2018

Marrow transplantation following busulfan and cyclophosphamide for chronic myelogenous leukaemia in accelerated or blastic phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-Host reactions: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell subsets and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704659

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704659

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/15361916

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53365188&oldid=1465419546"